about
Vitamin B for treating peripheral neuropathyRational treatment choices for non-major depressions in primary care: an evidence-based reviewEfficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic reviewVitamin neurotoxicitySensory neuronopathies.A review on radiogenic Lhermitte's sign.Methionine tumor starvation by erythrocyte-encapsulated methionine gamma-lyase activity controlled with per os vitamin B6.Pyridoxine administration improves behavioral and anatomical outcome after unilateral contusion injury in the rat.Characteristics of pyridoxine overdose neuropathy syndrome.Glutamate carboxypeptidase II inhibition behaviorally and physiologically improves pyridoxine-induced neuropathy in rats.Isoniazid toxicity with cerebellar ataxia in a child.Pyridoxal phosphate inhibits pituitary cell proliferation and hormone secretion.Who should take vitamin supplements?Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial.No sensory neuropathy during pyridoxine treatment in homocystinuria.Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies).Progressive polyradiculoneuropathy due to intraneural oxalate deposition in type 1 primary hyperoxaluriaGinkgotoxin Induced Seizure Caused by Vitamin B6 Deficiency.Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency.AAEM minimonograph #34: polyneuropathy: classification by nerve conduction studies and electromyography.Micronutrient safety.Pyridoxal isonicotinoyl hydrazone. Effective iron chelation after oral administration.Clinical assessment of the sensory ataxias; diagnostic algorithm with illustrative cases.Chronic idiopathic axonal polyneuropathy and vitamin B6: a controlled population-based study.Pharmacokinetics of vitamin B6 supplements in humans.Toxicity of vitamins.Vitamin B6 therapy during childbearing years: cause for caution?Paresthesias developing in an elderly patient after chronic usage of nitrofurantoin and vitamin B6.Antenatal treatment in two Dutch families with pyridoxine-dependent seizures.High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population.Pyridoxine-dependent seizures: a family phenotype that leads to severe cognitive deficits, regardless of treatment regime.The effect of different treatment regimens in reducing fasting and postmethionine-load homocysteine concentrations.Vitamin B6 repletion in cirrhosis with oral pyridoxine: failure to improve amino acid metabolism.Lack of efficacy of pyridoxine (vitamin B6) treatment in acquired idiopathic sideroblastic anaemia, including refractory anaemia with ring sideroblasts.Sensory NeuronopathiesVitamin B₆ and Its Role in Cell Metabolism and Physiology
P2860
Q24242086-C0754936-C8E6-4440-B33D-061A9D4436DDQ24550595-1F8103ED-3411-4375-8A8D-C140CD0C6D60Q24646555-25ABF0A1-FAAC-4829-9B84-4025981ACC9BQ28186901-51FB03C4-C6F8-468E-AB34-E475DBD7D0E3Q30278525-6D801DFA-F2C7-4D7F-8B40-6566593358CDQ30811595-67041B3A-6EC3-4CDB-ABEE-802C9A30CB54Q33775244-9F799CAC-8425-4B86-8B6C-AFCAF29A0058Q34142381-B17F1D39-6A2D-43E6-80BF-9D766848D167Q34186186-8A30EFD4-FA0D-4669-891F-C7603898A596Q34256889-FA72E918-50CD-4272-A7B3-2561C321B772Q34714688-7A2083BE-B96B-4159-8707-6B173AA25E23Q34803215-623BECB8-4314-4A89-991F-73F87BC45AA8Q35170103-B0E0A563-7149-44B2-ABC0-189BEFA10C04Q35237744-31A9B52E-BCA7-41C1-9939-4FC275D5C973Q35626640-C01E7933-015E-4BA8-A4A9-CB82FF9CBBF3Q35866323-B377307D-DAE8-4618-85F9-721B08A0ADCBQ36079435-8EA61E80-BAAF-40AF-8DEE-25CD85FDD127Q36496033-ADF46E3D-7EC9-4B53-8303-B70FACC5825BQ37547501-A19F21C1-66F6-487E-8016-A545C5FEB011Q37897506-7659F5B7-0EB1-4243-953F-2314F72ED738Q37936343-42ADE2D7-3FCB-41D5-8763-54F5876DF146Q38037032-DDC3F244-8B06-4DFD-92D8-F3029A5D99E4Q38191205-B34B0A25-916F-4F70-A4F9-DB99253A37E3Q38210650-4897B543-290F-4C01-AAF7-F310FFCED98AQ40968597-A59D4226-3E26-408C-AF4F-B65BBA5B61ADQ43172880-BC51F375-09E1-4B97-B077-EA7E86984977Q44095018-1A4235AF-7CCC-4A78-A367-22151EE9CB05Q44700583-D2C96C93-E213-42EC-8BA4-457DFCF6F7AFQ45934648-23371EF6-66E0-49D8-A90F-559D56B746B0Q46805478-06E9E637-E828-4AD3-B4A7-C6130D6893C0Q48233524-783D9084-BFD4-41F4-8232-A758210806CBQ51553967-158ADF35-33B9-4B84-83A5-30355DE36D16Q51621300-090D9E18-7E82-421F-A3AE-52ECB688B27FQ53157488-63B17EF9-8D2D-4B65-B934-B8A9F1F6D87CQ56501694-4D0F39F7-D2C2-47C1-A176-4C6BCA8E5355Q57175120-399F02EA-DBD0-49AF-A25C-B548A1FCDFDB
P2860
description
1985 nî lūn-bûn
@nan
1985 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Sensory neuropathy with low-dose pyridoxine.
@ast
Sensory neuropathy with low-dose pyridoxine.
@en
Sensory neuropathy with low-dose pyridoxine.
@nl
type
label
Sensory neuropathy with low-dose pyridoxine.
@ast
Sensory neuropathy with low-dose pyridoxine.
@en
Sensory neuropathy with low-dose pyridoxine.
@nl
prefLabel
Sensory neuropathy with low-dose pyridoxine.
@ast
Sensory neuropathy with low-dose pyridoxine.
@en
Sensory neuropathy with low-dose pyridoxine.
@nl
P356
P1433
P1476
Sensory neuropathy with low-dose pyridoxine.
@en
P2093
P304
P356
10.1212/WNL.35.10.1466
P407
P577
1985-10-01T00:00:00Z